Income Statement

DOLBY LABORATORIES, INC.

DLB
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Sep 30, 2025 2025 FY Sep 30, 2024 2024 FY Sep 30, 2023 2023 FY Sep 30, 2022 2022 FY Sep 30, 2021 2021 FY Sep 30, 2020 2020 FY Sep 30, 2019 2019 FY Sep 30, 2018 2018 FY Sep 30, 2017 2017 FY Sep 30, 2016 2016 FY Sep 30, 2015 2015 FY Sep 30, 2014 2014 FY Sep 30, 2013 2013 FY Sep 30, 2012 2012 FY Sep 30, 2011 2011 FY Sep 30, 2010 2010 FY
Revenue
1,349.13 1,273.72 1,299.74 1,253.79 1,281.26 1,161.79 1,241.62 1,171.92 1,081.45 1,025.74 970.64 960.18 909.67 926.26 955.51 922.71
Cost of Revenue
243.75 213.79 240.24 221.12 204.63 242.17 264.18 128.26 118.31 108.98 94.82 70.18 96.72 92.03 111.17 131.82
Gross Profit
1,189.00 1,133.23 1,147.18 1,112.43 1,151.23 1,015.29 1,080.77 1,043.66 963.15 916.76 875.82 890.00 812.96 834.24 844.33 790.90
Operating Expenses
924.04 874.90 931.43 905.83 806.84 796.55 823.69 743.67 714.52 684.96 662.59 616.28 567.69 472.25 414.60 361.52
Research & Development
261.79 263.66 271.52 261.17 253.64 239.05 237.87 236.79 233.31 219.61 201.32 183.13 168.75 140.14 123.92 104.98
Selling, General & Administrative
360.71 334.46 354.36 358.72 332.67 335.93 343.84 309.80 296.66 295.27 279.17 252.65 231.10 181.74 149.64 130.16
Other Operating Expenses
- - - - - - - - - - - - - - - -
Operating Income
264.96 258.33 215.75 206.61 344.39 218.74 257.08 300.00 248.63 231.80 213.23 273.72 245.26 361.99 429.73 429.38
Non-Operating Income
38.53 54.15 34.30 8.67 10.12 20.97 25.23 12.87 8.01 4.11 32.55 2.38 -5.38 -7.00 -10.91 -7.63
Interest Income
- - - 6.57 3.49 12.73 24.92 18.97 9.58 5.68 4.54 3.34 3.85 6.41 8.98 7.30
Interest Expense
- - - 0.39 0.48 0.19 0.17 0.20 0.13 0.13 0.18 -0.18 0.58 0.20 -1.03 0.70
Other Non-Op Income / Expense
-24.07 14.20 5.10 5.00 7.11 8.43 0.48 -5.90 -1.44 -1.45 28.19 -1.15 2.11 0.78 0.91 1.04
Income Before Tax
303.49 312.48 250.05 215.28 354.51 239.72 282.31 312.87 256.64 235.90 245.78 276.10 250.65 368.99 440.64 437.01
Income Tax Expense
48.47 50.65 49.40 31.19 44.29 8.35 27.16 190.62 54.84 50.04 64.39 70.00 61.38 104.69 131.38 153.57
Non-Controlling Interest
1.47 2.49 0.99 -0.19 7.60 0.26 0.35 0.56 0.63 0.54 1.85 2.62 1.03 0.83 1.32 -0.62
Net Income
255.02 261.83 200.66 184.09 310.23 231.36 255.15 122.25 201.80 185.86 181.39 206.10 189.27 264.30 309.27 283.45
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Sep 30, 2025 2025 FY Sep 30, 2024 2024 FY Sep 30, 2023 2023 FY Sep 30, 2022 2022 FY Sep 30, 2021 2021 FY Sep 30, 2020 2020 FY Sep 30, 2019 2019 FY Sep 30, 2018 2018 FY Sep 30, 2017 2017 FY Sep 30, 2016 2016 FY Sep 30, 2015 2015 FY Sep 30, 2014 2014 FY Sep 30, 2013 2013 FY Sep 30, 2012 2012 FY Sep 30, 2011 2011 FY Sep 30, 2010 2010 FY
Depreciation & Amortization
- - - - - - - - - - - - - - - -
EBITDA
352.79 333.89 298.31 295.07 440.25 309.62 342.20 381.28 332.94 316.95 282.36 327.00 298.51 405.87 473.73 464.32
Earnings Per Share (Basic)
2.66 2.74 2.10 1.84 3.07 2.30 2.51 1.18 1.98 1.85 1.77 2.02 1.86 2.47 2.78 2.50
Diluted EPS
2.62 2.69 2.05 1.81 2.97 2.25 2.44 1.14 1.95 1.81 1.75 1.99 1.84 2.46 2.75 2.46
Weighted Average Shares
95.87 95.54 95.77 99.99 101.19 100.56 101.63 103.38 101.78 100.72 102.35 102.15 101.88 106.93 111.44 113.45
Diluted Weighted Avg Shares
97.48 97.33 97.73 101.98 104.62 102.94 104.57 106.98 103.29 102.42 103.86 103.63 102.79 107.54 112.55 115.39
Comprehensive Income
261.69 279.62 215.31 142.48 310.79 241.39 250.36 114.17 204.25 187.13 166.90 201.30 186.40 267.46 309.00 -